Correlation of epigenetic aberrance with STAT3 signaling pathway in gastric carcinogenesis

Digestive Diseases and Sciences

Volumn 57, Issue 8, 2012, Pages 2055-2062

  Gao, Fuli ^a   Lv, Ying ^a   Zhu, Yinxin ^a   Chen, Min ^a   Shen, Shanshan ^a   Cao, Jun ^a   Zou, Xiaoping ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Epigenetics; Gastric cancer; Precancerous lesion; STAT3

Indexed keywords

DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR EZH2;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GENETICS; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY CANCER; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM;

AGED; AGED, 80 AND OVER; CARCINOMA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; HISTONE DEACETYLASE 1; HUMANS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84866404205     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2152-1     Document Type: Article

References (25)

1. No authors listed. Gastric cancer incidence rate to rise. Manag Care. 2010;19:49.
2. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:S37-S43.
3. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60:337-350.
4. Chao C, Hellmich MR. Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes. 2010;17:33-39.
5. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31:27-36.
6. Etoh T, Kanai Y, Ushijima S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol. 2004;164:689-699.
7. Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol. 2010;17:3336-3343.
8. Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci. 2006; 97:484-491.
9. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108:1058-1064.
10. Gupta M, Stenson M, Lasho T, et al. Interplay between histone deacetylases (HDACs) and STAT3: mechanism of activated JAK/STAT3 oncogenic pathway in ABC (activated B-cell) type diffuse large B cell lymphoma. Abstract 925. Blood. 2009;114: 381.
11. Yeh HY, Cheng SW, Lin YC, Yeh CY, Lin SF, Soo VW. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency. BMC Med Genomics. 2009;2: 70.
12. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560.
13. Yakata Y, Nakayama T, Yoshizaki A, Kusaba T, Inoue K, Sekine I. Expression of pSTAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol. 2007;30:437-442.
14. Jackson CB, Giraud AS. STAT3 as a prognostic marker in human gastric cancer. J Gastroenterol Hepatol. 2009;24:505-507.
15. Deng JY, Sun D, Liu XY, Pan Y, Liang H. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol. 2010;16:5380-5387.
16. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108:1058-1064.
17. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3 - and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA. 2005;102:6948-6953.
18. Schuettengruber B, Simboeck E, Khier H, Seiser C. Autoregulation of mouse histone deacetylase 1 expression. Mol Cell Biol. 2003;23:6993-7004.
19. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003;83:635-641.
20. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40: 1534-1542.
21. Zeng J, Ge Z, Wang L, et al. The histone demethylase RBP2 is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology. 2010;138:981-992.
22. Weichert W, Röske A, Gekeler V, et al. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol. 2008;9: 139-148.
23. Choi JH, Song YS, Yoon JS, Song KW, Lee YY. Enhancer of zeste homolog 2 expressions is associated with tumor cell proliferation and metastasis in gastric cancer. APMIS. 2010;118: 196-202.
24. Meng CF, Zhu XJ, Peng G, et al. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine- DNA methyltransferase gene expression in human stomach cancer cells. Cancer Invest. 2010;28:331-339.
25. Ding WJ, Fang JY, Chen XY, Peng YS. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci. 2008;53:2083-2089.